版权说明 操作指南
首页 > 成果 > 详情

Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signaling

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Qin, Li;Yang, Yun-bo;Yang, Yi-xin;Zhu, Neng;Gong, Yong-zhen;...
通讯作者:
Liao, Duan-fang
作者机构:
[Yang, Yun-bo; Liao, Duan-fang; Li, Shun-xiang; Gong, Yong-zhen; Qin, Li] Hunan Univ Chinese Med, Sch Pharm, Div Stem Cell Regulat & Applicat, Changsha 410208, Hunan, Peoples R China.
[Zhang, Cai-ping; Qin, Li] South China Univ, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China.
[Yang, Yun-bo; Yang, Yi-xin] Univ Western Ontario, London Hlth Sci Ctr, Matthew Mailing Ctr Translat Transplantat Studies, London, ON N6A 5A5, Canada.
[Yang, Yun-bo; Zhu, Neng] Cent S Univ, Xiang Ya Hosp 2, Changsha 410011, Hunan, Peoples R China.
[Zhu, Neng] South China Univ, Affiliated Hosp 2, Hengyang 421001, Peoples R China.
通讯机构:
[Liao, Duan-fang] H
Hunan Univ Chinese Med, Sch Pharm, Div Stem Cell Regulat & Applicat, Changsha 410208, Hunan, Peoples R China.
语种:
英文
关键词:
atherosclerosis;vascular smooth muscle cells;cholesterol;ezetimibe;caveolin-1;SREBP-1;MAPK
关键词(中文):
血管平滑肌细胞;MAPK信号通路;胆固醇水平;体外;信号抑制;WESTERN印迹;高效液相色谱法
期刊:
中国药理学报
ISSN:
1671-4083
年:
2014
卷:
35
期:
9
页码:
1129-1136
基金类别:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000946, 81270359, 81173047, 12JJ5068]; Construct Program of the Pharmaceutical Science Key Discipline in Hunan province
机构署名:
本校为第一且通讯机构
院系归属:
药学院
摘要:
Aim: To investigate the mechanisms of anti-atherosclerotic action of ezetimibe in rat vascular smooth muscle cells (VSMCs) in vitro. Methods: VSMCs of SD rats were cultured in the presence of Chol:MβCD (10 μg/mL) for 72 h, and intracellular lipid droplets and cholesterol levels were evaluated using Oil Red O staining, HPLC and Enzymatic Fluorescence Assay, respectively. The expression of caveolin-1,sterol response element-binding protein-1 (SREBP-1) and ERK1/2 were analyzed using Western blot assays. Translocation of SREBP-1 and ERK1/2 was d...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com